The pen is mightier than the sword
InsulinPublished 1 July 2009
Charles F. Shaefer
Citations10
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Physicians, patients, and payors should recognize that making it easier for patients to take better care of their diabetes is not a trivial benefit, and reducing this barrier could make an important contribution to improved diabetes outcomes.
Abstract
Rubin and Peyrot20 summarized the situation well, saying "physicians, patients, and payors should recognize that making it easier for patients to take better care of their diabetes is not a trivial benefit. Burden of treatment is a significant barrier to improved self-care, and reducing this barrier could make an important contribution to improved diabetes outcomes." Perhaps we have not yet done the right study to show a beneficial effect on A1C levels.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Diabetes CareThe Treat-to-Target Trial
1,477 Citations2003Matthew C. Riddle, Julio Rosenstock +2 more
Systematically titrating bedtime basal insulin added to oral therapy can safely achieve 7% HbA(1c) in a majority of overweight patients with type 2 diabetes, thus reducing a leading barrier to initiating insulin.
New England Journal of MedicineAddition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
709 Citations2007Rury R. Holman, Kerensa Thorne +5 more
The addition of biphasic or prandial insulin aspart reduced levels more than the addition of basal insulin detemir but was associated with greater risks of hypoglycemia and weight gain.
Clinical TherapeuticsMedication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
262 Citations2006Won Chan Lee, Sanjeev Balu +3 more
Among patients with type 2 diabetes treated in a managed care setting, a switch from administration of insulin therapy by vial/syringe to a prefilled insulin analogue pen device was associated with improved medication adherence, fewer claims for hypoglycemic events, reduced emergency department and physician visits, and lower annual treatment costs.
Clinical TherapeuticsHealth Care Costs and Medication Adherence Associated with Initiation of Insulin Pen Therapy in Medicaid-Enrolled Patients with Type 2 Diabetes: A Retrospective Database Analysis
112 Citations2007Manjiri Pawaskar, Fabian Camacho +4 more
In a state Medicaid setting among patients with type 2 diabetes, initiating insulin therapy with a pen device was associated with comparable medication adherence and significant reductions in health care resource utilization and associated costs compared with vial/syringe insulin.
Diabetes CareFactors Affecting Use of Insulin Pens by Patients With Type 2 Diabetes
72 Citations2008Richard R. Rubin, Mark Peyrot
Current Medical Research and OpinionAn evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe
69 Citations2006Karen M. Stockl, Caron Ory +5 more
The majority of patients preferred the disposable doser, and reported significantly less fear of self-injection using this delivery system, and insulin may have greater patient acceptance and less psychological distress when administered via an alternative delivery system.
Expert Opinion on Drug DeliveryDose accuracy and injection force dynamics of a novel disposable insulin pen
65 Citations2007Alastair Clarke, Geralyn Spollett
Comparisons between SoloStar and two commonly used pens, FlexPen® (Novo Nordisk) and the Humulin®/Humalog® pen (Eli Lilly) establish SoloStar as a state of the art pen that is suitable for most patients with diabetes.
Diabetes Research and Clinical PracticeInsulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations
64 Citations1990Jan Olof Hörnquist, Anders Wikby +2 more
The pen contributes to a better life for the IDDM patient and the quality of life changes due to treatment intervention appear to be assessable, corroborated by recent studies with other designs and methods.
Diabetic MedicineA Randomized Trial of the Efficacy and Acceptability of a Pen Injector
47 Citations1988Diana Murray, P. Keenan +5 more
There was no significant change in mean glycosylated haemoglobin, in blood glucose profiles or in frequency of hypoglycaemic attacks in either group over the 20 weeks, and high patient satisfaction with the pen injector (NovoPen) was demonstrated.
Endocrine PracticeInsulin Management of Diabetic Patients on General Medical and Surgical Floors
34 Citations2006Jack L. Leahy
Standardized protocols have been developed and implemented at the University of Vermont for patients receiving regular meals and continuous tube feedings or TPN for diabetic patients on general medical and surgical floors.
The Diabetes EducatorMetabolic Control, Quality of Life, and Negative Life Events: A Longitudinal Study of Well-Controlled and Poorly Regulated Patients With Type 1 Diabetes After Changeover to Insulin Pen Treatment
17 Citations1998Anders Wikby, Ulf Stenström +2 more
For the group as a whole, quality of life was found to change only moderately, whereas metabolic control deteriorated significantly across time following transition to the insulin pen, and the clinical suitability of a multiple injection regimen is discussed.
Journal of the American Academy of Nurse PractitionersUse of an Insulin Pen by Homeless Patients with Diabetes Mellitus
16 Citations2002Terry Wilk, Pablo F. Mora +2 more
It was concluded that use of the pen improved patient compliance and thus glycemic control, and patients had improved quality of life after using the pen to administer insulin.
PubMedExamining economic improvements in managing diabetes in the nursing home.
1 Citations1999Sherrie Dornberger, D Stone +1 more
The development of the Insulin Delivery Pen system can provide cost efficiency, and concurrently reduce the potential for contamination, free up nursing time, improve the administration process, and maintain dosing accuracy.